Cargando…

Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis

BACKGROUND: Acute decompensation (AD) has been shown to be associated with a high mortality rate for cirrhosis patients. This study aimed to develop a prognostic nomogram to evaluating the individual prognosis for AD of cirrhosis in chronic hepatitis B (CHB). METHODS: The nomogram was developed usin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Fangyuan, Li, Xiaoshu, Wan, Gang, Li, Yuxin, Zhang, Qun, Liu, Yao, Liu, Huimin, Li, Hai, Wang, Xianbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276255/ https://www.ncbi.nlm.nih.gov/pubmed/30509201 http://dx.doi.org/10.1186/s12876-018-0911-y

Ejemplares similares

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma
por: Wan, Gang, et al.
Publicado: (2017)

Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals
por: Shi, Ke, et al.
Publicado: (2023)

Derivation and Validation of a Prognostic Model for Acute Decompensated Cirrhosis Patients
por: Zhang, Yue, et al.
Publicado: (2023)

Platelet Count/Spleen Thickness Ratio and the Risk of Variceal Bleeding in Cirrhosis With Esophagogastric Varices
por: Liu, Huimin, et al.
Publicado: (2022)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Establishment and Validation of a Non-Invasive Diagnostic Nomogram to Identify Spontaneous Bacterial Peritonitis in Patients With Decompensated Cirrhosis
por: Xiang, Shoushu, et al.
Publicado: (2022)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Entecavir for Patients with Hepatitis B Decompensated Cirrhosis in China: a meta-analysis
por: Wang, F.Y., et al.
Publicado: (2016)

Sofosbuvir and ribavirin in acute hepatitis C–infected patient with decompensated cirrhosis
por: Liu, Hui, et al.
Publicado: (2016)

Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies
por: Liu, Jing, et al.
Publicado: (2020)

Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis
por: Cai, Qun, et al.
Publicado: (2019)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

External validation of the first prognostic nomogram for older adults with cancer
por: Tay, Yu Ling, et al.
Publicado: (2023)

Evolution of care in cirrhosis: Preventing hepatic decompensation through pharmacotherapy
por: Lee, Seohyuk, et al.
Publicado: (2023)

Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis
por: Shi, Ke, et al.
Publicado: (2020)

Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020)

New prognostic factor for hepatitis B virus‐related decompensated cirrhosis: Ratio of monocytes to HDL‐cholesterol
por: Wu, Qianxia, et al.
Publicado: (2021)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Establishment and validation of a prognosis nomogram for MIMIC-III patients with liver cirrhosis complicated with hepatic encephalopathy
por: Yan, Wansheng, et al.
Publicado: (2023)

Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry
por: Liu, Jianjun, et al.
Publicado: (2016)

Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis
por: Jiang, Qun-Qun, et al.
Publicado: (2018)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
por: Valpione, Sara, et al.
Publicado: (2015)

Splenectomy prior to antiviral therapy in patients with hepatitis C virus related decompensated cirrhosis
por: Ji, Fanpu, et al.
Publicado: (2013)

Cystatin C and interleukin‐6 for prognosticating patients with acute decompensation of cirrhosis
por: Padia, Gaurav, et al.
Publicado: (2021)

Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications
por: Baldassarre, Maurizio, et al.
Publicado: (2021)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

Prognostic value of neutrophil count to albumin ratio in patients with decompensated cirrhosis
por: Yao, Junjie, et al.
Publicado: (2023)

Nomogram for Individualized Prediction of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis on Conservative Treatment
por: Liu, Yao, et al.
Publicado: (2020)

Hepatic Myelopathy in a Patient with Decompensated Alcoholic Cirrhosis and Portal Colopathy
por: Premkumar, Madhumita, et al.
Publicado: (2012)

Serum Sphingolipid Variations Associate with Hepatic Decompensation and Survival in Patients with Cirrhosis
por: Grammatikos, Georgios, et al.
Publicado: (2015)

Invasive pulmonary mucormycosis and aspergillosis in a patient with decompensated hepatic cirrhosis
por: Persichino, Jon G., et al.
Publicado: (2018)

Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis
por: Lee, Soon Kyu, et al.
Publicado: (2017)

Postoperative Risk of Hepatic Decompensation after Orthopedic Surgery in Patients with Cirrhosis
por: Nyberg, Eric M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ctnt5utrf9ldrv3m9gr253si33